Zimmer Biomet
939 hedge funds and large institutions have $17.6B invested in Zimmer Biomet in 2025 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 308 increasing their positions, 364 reducing their positions, and 147 closing their positions.
42% more capital inflows, than outflows
Capital inflows: $2.4B | Capital outflows: $1.69B
4.54% more ownership
Funds ownership: 93.08% → 97.62% (+4.5%)
7% less funds holding
Funds holding: 1,007 → 939 (-68)
15% less repeat investments, than reductions
Existing positions increased: 308 | Existing positions reduced: 364
39% less first-time investments, than exits
New positions opened: 90 | Existing positions closed: 147
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
50% less call options, than puts
Call options by funds: $27.5M | Put options by funds: $55.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$655M |
| 2 |
Harris Associates
Chicago,
Illinois
|
+$361M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$245M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$141M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$92.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$198M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$175M |
| 3 |
Camber Capital Management
Boston,
Massachusetts
|
-$121M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$113M |
| 5 |
JP Morgan Chase
New York
|
-$111M |
ZBH Hedge Fund Activity: Q2 2025 in Review
939 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2025, worth a combined $17.6B — down 16% from $21B a quarter earlier.
Sellers outnumbered buyers: 147 funds closed out of ZBH and 90 opened new positions — a net loss of 57 holders — while 364 trimmed existing stakes and 308 added.
The largest buyer was Capital International Investors, opening a new position worth an estimated $655M. The largest seller was Citadel Advisors, exiting entirely with an estimated $198M sold.
- 939 institutional investors held Zimmer Biomet (ZBH) as of Q2 2025, down from 1,007 in Q1 2025.
- Funds reported $17.6B of Zimmer Biomet stock for Q2 2025, down 16% quarter-over-quarter.
- 90 funds opened new Zimmer Biomet positions in Q2 2025 and 147 closed out, a net change of -57 holders.
- The largest Zimmer Biomet buyer in Q2 2025 was Capital International Investors, an estimated $655M added.
- The largest Zimmer Biomet seller in Q2 2025 was Citadel Advisors, an estimated $198M sold.
Based on aggregated 13F filings for Q2 2025.